Pfizer

Quick Read PFE’s 7.27% yield looks safe on a 53% adjusted payout ratio, but free cash flow fell…

For millions of people taking weight loss drugs, the next breakthrough may not be more weight loss. It…

Chai Discovery cofounders Josh Meier (left) and Jack Dent Cody Pickens for Forbes L ast June, when AI…

Investors seeking reliable dividends and healthcare exposure often find themselves choosing between AbbVie (NYSE:ABBV) and Pfizer (NYSE:PFE). Both…

Pfizer (NYSE: PFE) is facing patent expirations for some of its biggest drugs. That’s normal for a pharmaceutical…

A company with a $140 billion market cap is very large. It is also highly likely to be…

In early May 2026, Pfizer reported first-quarter revenue of US$14.45 billion and net income of US$2.69 billion, with earnings per…

Novo Nordisk NVO and Pfizer PFE are both pharmaceutical giants based in Denmark and the United States, respectively, with…

As large tech companies struggled this year, investors have had a chance to reevaluate their portfolios and identify…

Many of the top companies successfully cashing in on artificial intelligence (AI) are in the technology sector. However,…

A number of major drugmakers have reportedly raised the prices of hundreds of brand-name drugs, including some of…

Pharmaceutical giant Pfizer (NYSE: PFE) recently had to drop its internally developed GLP-1 weight loss drug candidate. The…

This 7% Yielding Healthcare Powerhouse Belongs in Retirees’ Portfolios